TAV64

N/A

Report date: 2023/04/24 10:45:59
NME

Base Information

Drug NameTAV64
Drug Alias NameTAV64TAV-64TAV64015TAV-64015TAV64040 +[8] 
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSystemic Inflammatory Response Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesYnios Pharma SRL
China Registration ClassN/A

Develop Information

Active CompaniesYnios Pharma SRL
Inactive CompaniesN/A
Active IndicationsSystemic Inflammatory Response Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A